DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma
Jeffrey Zuccato(University of Oklahoma), Gelareh Zadeh(University Health Network), Shahbaz Khan(University Health Network), Jeffrey Liu(Fox Chase Cancer Center), Namita Sinha(University of Manitoba), Ankur Chakravarthy(Princess Margaret Cancer Centre), Shirin Karimi(University Health Network), Olivia Singh(University Health Network), Thomas Kislinger(University Health Network), Anne-Laure Bernat(Université Paris Cité), Yasin Mamatjan(Princess Margaret Cancer Centre), Sébastien Froelich(Université Paris Cité), João Paulo Almeida(University of Toronto), Kenneth Aldape(National Institutes of Health), Daniel D. De Carvalho(University Health Network), Vikas Patil(University Health Network), Mohammed Hasen(King Fahd Hospital of the University), Homa Adle‐Biassette(Université Claude Bernard Lyon 1), Sheila Mansouri(Princess Margaret Cancer Centre), Farshad Nassiri(University Health Network)
Cited by 62
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Challenges to curing primary brain tumours
|Nature Reviews Clinical Oncology|2019|965